VALIDATE 2023 convenes in Miami October 4-5 showcasing the latest in digital transformation for Validation professionals in Life Sciences

LIMERICK, Ireland, September 6, 2023 /CNW/ – kneat.com, inc. (the “Company” or “Kneat”) (TSX: KSI) (OTC: KSIOF), a leader in digitizing and automating validation and quality processes, is bringing together quality professionals from around the world to discover and apply validation technologies, regulations, and best practices.  Participants from across the industry will present, including practitioners from Merck, Sanofi, Eli Lilly and Fujirebio Diagnostics. 

This year’s conference theme, Digitization and Change, is inspired by the the Validation 4.0 initiative and challenge of guiding organizations through validation’s inevitable transition to a digital future.  Multiple expert-led conference sessions will offer insights into validation, technology, and best practices and explore: 

• Integrating digital validation with other key systems to drive value
• Verification of true copies 
• Audit readiness in the digital environment 
• Organization change management 
• Gaining buy-in and user adoption 
• User impact assessments and why they are critical to change management 

“Makers of life-saving and life-enhancing therapies cannot fully leverage and scale the innovations that are coming available without transitioning fully to digital,” said Eddie Ryan, CEO of Kneat.  “This means the entire quality assurance fabric underlying development, production and distribution needs to be fully digitized along with everything else.  The people coming to VALIDATE know that scanning in paper documents doesn’t solve it, and they are leading the way for their organizations to validation that is efficient, hardened, and easily auditable.” 

VALIDATE 2023, to be held in Miami October 4-5, is designed for life sciences professionals looking to understand and apply the technologies, metrics, and operational strategy required to drive effective digitalization. At the inaugural VALIDATE conference in Boston in November 2022, 100% of respondents to an attendee survey said they would recommend VALIDATE to their colleagues. 

 Register for VALIDATE 2023 at www.validateconference.com 

About Kneat 

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx SaaS platform. Multiple business work processes can be configured on the platform from equipment to computer validation, through to quality document management. Kneat’s software allows users to author, review, approve, execute testing online, manage any exceptions, and post-approve final deliverables in a controlled FDA 21 CFR Part 11/ EU Annex 11-compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit  www.kneat.com 

Contact: 

Madison Adams, Global Manager, Events & Partner Marketing 
P: + 1 613-807-9403
E: madison.adams@kneat.com 

Author: Madison Adams